Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Msci Inc (MSCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Msci Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Msci Inc trades at $565.81 (market cap $40.75B). The key difference: Msci Inc is far larger — about 4.8× Hinge Health Inc. Class A Common Stock's market cap, and Msci Inc pays a 1.46% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Msci Inc for 83 Days on average.
| HNGE | MSCI | |
|---|---|---|
Market Cap | $8.47B | $40.75B |
Volume | 1,624,526 | 548,630 |
Sector | Health | Financials |
52-Week High | $105.14 | $643.83 |
52-Week Low | $31.17 | $511.84 |
Typical Hold Time | 0 Days | 83 Days |
Enterprise Value | $8.09B | $46.92B |
Dividend Yield | — | 1.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
MSCI trades at $560.82, down 1.27% on the day, with a bullish technical signal and strong fundamental performance. Revenue grew to $3.13B in 2025, with a net income margin of 40.73%. The company recently completed the acquisition of First Street, expanding its climate risk analytics offerings. Analyst consensus is strongly bullish with a $701.71 price target, indicating significant upside potential from current levels.
The outlook for MSCI remains positive due to consistent earnings beats, high profitability margins, and strategic acquisitions. Key risks include high valuation multiples and substantial long-term debt of $4.51B. Institutional sentiment supports growth, but investors should monitor execution of integration strategies and macroeconomic factors affecting financial markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Msci Inc
MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Read more on MSCI →
